首页> 外文期刊>Microsurgery. >Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers
【24h】

Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers

机译:BRCA1和BRCA2携带者的预防性子宫切除术,卵巢切除术,乳房切除术和显微外科乳房重建的时机

获取原文
获取原文并翻译 | 示例
           

摘要

Background BRCA (breast cancer susceptibility gene) carriers are at high risk for breast and ovarian malignancies, and often undergo prophylactic total abdominal hysterectomy-bilateral salpingo-oophorectomy (TAH-BSO), bilateral mastectomy, and microsurgical breast reconstruction. Our goal was to determine whether abdominal wall complications and flap choice are affected by the order of those procedures. Methods All BRCA carriers who underwent microsurgical breast reconstruction between 2007 and 2012 were studied. Abdominal wall complications and changes in the reconstructive plan were analyzed depending on the order of breast reconstruction and TAH-BSO. Results 442 patients underwent 612 microsurgical breast reconstructions, 47 of whom were BRCA carriers. TAH-BSO was not a predictor of requiring mesh for fascial closure (OR 1.1, P = 0.8), or of hernia/bulge (OR = 1.6, P = 0.65). In five patients, a DIEP flap was altered to another flap as a direct result of prior TAH-BSO. Robotic TAH-BSO after breast reconstruction took longer to perform than before breast reconstruction (4.48 ± 1.00 hours vs. 3.23 ± 0.70 hours, respectively, P = 0.023), due to abdominal wall tightness. However, none were converted to open. Full-muscle free TRAM flaps (compared to other flaps) and bilateral reconstructions (compared to unilateral) were the only predictors of mesh (OR = 9.85, P < 0.001 and 4.01, P < 0.001), and hernia/bulge (OR = 6.18, P < 0.001 and 2.13, P = 0.07). The order of TAH-BSO and breast reconstruction did not affect complications. Conclusions In BRCA carriers, the order of TAH-BSO and microsurgical breast reconstruction does not affect complication rates. However, prior TAH-BSO may make DIEP flaps unfeasible, and robotic TAH-BSO after breast reconstruction takes longer, but can still be performed safely.
机译:背景BRCA(乳腺癌易感基因)携带者罹患乳腺癌和卵巢恶性肿瘤的风险很高,并且经常接受预防性全腹子宫全切除-双侧输卵管卵巢切除术(TAH-BSO),双侧乳房切除术和显微外科乳房重建术。我们的目标是确定腹壁并发症和皮瓣的选择是否受这些手术顺序的影响。方法研究2007年至2012年间所有接受乳腺癌微创手术的BRCA携带者。根据乳房重建的顺序和TAH-BSO,分析了腹壁并发症和重建计划的变化。结果442例患者接受了612例乳房微手术,其中47例为BRCA携带者。 TAH-BSO不能预测筋膜闭合需要网片(OR 1.1,P = 0.8)或疝气/隆起(OR = 1.6,P = 0.65)。在5例患者中,由于先前TAH-BSO的直接结果,DIEP皮瓣被更改为另一皮瓣。由于腹壁的紧缩,乳房再造后的机器人TAH-BSO的执行时间要比乳房再造前更长(分别为4.48±1.00小时和3.23±0.70小时,P = 0.023)。但是,没有一个转换为打开状态。全肌游离TRAM皮瓣(与其他皮瓣相比)和双侧重建(与单侧皮瓣相比)是唯一的网状(OR = 9.85,P <0.001和4.01,P <0.001)和疝气/隆起(OR = 6.18)的预测指标,P <0.001和2.13,P = 0.07)。 TAH-BSO的顺序和乳房再造不影响并发症。结论在BRCA携带者中,TAH-BSO的顺序和显微外科乳房重建术不会影响并发症发生率。但是,先前的TAH-BSO可能会使DIEP瓣不可行,并且乳房重建后的机器人TAH-BSO需要更长的时间,但仍可以安全地进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号